Table 2.

Patient, tumor, and treatment characteristics.

		Number%
Gender	Male	221	76.2
	Female	69	23.8
Age	≤60	142	49.0
	˃60	148	51.0
Weight loss	≤%5	143	49.0
	˃%5	147	50.7
Weight loss	≤%10	248	85.5
	˃%10	42	14.5
KPS	90–100	197	67.9
	60–80	93	32.1
Nutritional intervention	No	128	44.1
	Yes	162	55.9
NG	No	253	87.2
	Yes	37	12.8
Gastrostomy	No	165	56.9
	Yes	125	43.1
Primary	Oropharynx	139	47.9
	Oral Cavity	48	16.6
	Larynx	44	15.2
	Hypopharynx	23	7.9
	Unknown primary	18	6.2
	Sinonasal	12	4.1
	Nasopharynx	6	2.1
T stage	T0	22	7.6
	T1	44	15.2
	T2	92	31.7
	T3	66	22.8
	T4	66	22.8
N stage	N0	71	24.5
	N1	30	10.3
	N2	182	62.8
	N3	7	2.4
Stage	Stage I	7	2.4
	Stage II	23	7.9
	Stage III	44	15.2
	Stage IV	216	74.5
Radiation	Radical	200	69.0
	Adjuvant	90	31.0
Chemoradiotherapy	Radiotherapy	141	48.6
	Concurrent CRT	149	51.4
Induction CT	No	276	95.2
	Yes	14	4.8

KPS, Karnofsky performance status; NG, nasogastric tube; CT, chemotherapy.